Featured Research

from universities, journals, and other organizations

Designing embryo transfer policies: What's at issue?

Date:
August 6, 2014
Source:
Women & Infants Hospital
Summary:
A commentary has been published that focuses on neonatal outcomes when designing embryo transfer policies. "While preterm birth is an important factor to consider in subsequent preterm birth risk, one wonders whether a more accurate prediction could be generated using a more complex model," the author writes.

Brenna Anderson, MD, of the Division of Maternal-Fetal Medicine at Women & Infants of Rhode Island and an associate professor of obstetrics and gynecology at The Warren Alpert Medical School of Brown University, has published a commentary in the current issue of BJOG: An International Journal of Obstetrics and Gynaecology, now available online. The commentary is entitled "The time has come to consider neonatal outcomes when designing embryo transfer policies."

Related Articles


Dr. Anderson offers her commentary in response to an article in the same issue by Kamphius et al. in which the authors seek to determine "whether an individual's preterm birth risk should be incorporated into embryo transfer policy for women undergoing in vitro fertilization."

Dr. Anderson writes, "Kamphius et al. considered only one risk factor for preterm birth, albeit the most important one: prior preterm birth … While preterm birth is an important factor to consider in subsequent preterm birth risk, one wonders whether a more accurate prediction could be generated using a more complex model, akin to the model developed as part of the Eunice Kenney Shriver National Institutes of Child Health and Human Development's Neonatal Research Network's calculator for outcomes among extremely preterm infants."

She explains that this model calculates risk of preterm birth using five clinical factors: gestational age at birth, birthweight, gender, receipt of antenatal corticosteroids, and multiple gestations. "This calculator might provide a risk of preterm birth as well as an average anticipated length of gestation," Dr. Anderson explains. "Such a tool, if reliable and easy to use, would be highly useful for patients and clinicians contemplating embryo transfer."


Story Source:

The above story is based on materials provided by Women & Infants Hospital. Note: Materials may be edited for content and length.


Journal Reference:

  1. BL Anderson. The time has come to consider neonatal outcomes when designing embryo transfer policies. BJOG: An International Journal of Obstetrics and Gynaecology, August 2014 DOI: 10.1111/1471-0528.13002

Cite This Page:

Women & Infants Hospital. "Designing embryo transfer policies: What's at issue?." ScienceDaily. ScienceDaily, 6 August 2014. <www.sciencedaily.com/releases/2014/08/140806154009.htm>.
Women & Infants Hospital. (2014, August 6). Designing embryo transfer policies: What's at issue?. ScienceDaily. Retrieved November 27, 2014 from www.sciencedaily.com/releases/2014/08/140806154009.htm
Women & Infants Hospital. "Designing embryo transfer policies: What's at issue?." ScienceDaily. www.sciencedaily.com/releases/2014/08/140806154009.htm (accessed November 27, 2014).

Share This


More From ScienceDaily



More Health & Medicine News

Thursday, November 27, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Leaves Orphans Alone in Sierra Leone

Ebola Leaves Orphans Alone in Sierra Leone

AFP (Nov. 27, 2014) — The Ebola epidemic sweeping Sierra Leone is having a profound effect on the country's children, many of whom have been left without any family members to support them. Duration: 01:02 Video provided by AFP
Powered by NewsLook.com
Experimental Ebola Vaccine Shows Promise In Human Trial

Experimental Ebola Vaccine Shows Promise In Human Trial

Newsy (Nov. 27, 2014) — A recent test of a prototype Ebola vaccine generated an immune response to the disease in subjects. Video provided by Newsy
Powered by NewsLook.com
Pet Dogs to Be Used in Anti-Ageing Trial

Pet Dogs to Be Used in Anti-Ageing Trial

Reuters - Innovations Video Online (Nov. 26, 2014) — Researchers in the United States are preparing to discover whether a drug commonly used in human organ transplants can extend the lifespan and health quality of pet dogs. Video provided by Reuters
Powered by NewsLook.com
Today's Prostheses Are More Capable Than Ever

Today's Prostheses Are More Capable Than Ever

Newsy (Nov. 26, 2014) — Advances in prosthetics are making replacement body parts stronger and more lifelike than they’ve ever been. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
 
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:  

Breaking News:

Strange & Offbeat Stories

 

Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:  

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile iPhone Android Web
Follow Facebook Twitter Google+
Subscribe RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins